{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:58:46Z","timestamp":1784591926437,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006556","name":"Centre Hospitalier Universitaire de Toulouse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jaip.2024.12.034","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T12:37:41Z","timestamp":1735648661000},"page":"923-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lifetime Disability-Adjusted Life-Year Assessment of Indolent Systemic Mastocytosis"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0298-267X","authenticated-orcid":false,"given":"Michael","family":"Mouni\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne Derumeaux","family":"Burel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Molinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Bulai","family":"Livideanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.12.034_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2024.12.034_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/1651-226X.2024.31406","article-title":"Epidemiology of mastocytosis: a population based study Sweden","volume":"63","author":"Bergstr\u00f6m","year":"2024","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jaip.2024.12.034_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001414","article-title":"A\u00a0French national survey on clotting disorders in mastocytosis","volume":"94","author":"Carvalhosa","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jaip.2024.12.034_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","article-title":"Epidemiology, prognosis, and risk factors in mastocytosis","volume":"34","author":"Brockow","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.12.034_bib5","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.12.034_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.25371","article-title":"Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management","volume":"94","author":"Pardanani","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2024.12.034_bib7","doi-asserted-by":"crossref","DOI":"10.1017\/S146342362200024X","article-title":"How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis","volume":"23","author":"Hamberg Levedahl","year":"2022","journal-title":"Prim Health Care Res Dev"},{"key":"10.1016\/j.jaip.2024.12.034_bib8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13023-021-02037-3","article-title":"Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study","volume":"16","author":"Padilla","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2024.12.034_bib9","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/all.12920","article-title":"Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis","volume":"71","author":"Van Anrooij","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.12.034_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.iac.2018.04.006","article-title":"Patient perceptions in mast cell disorders","volume":"38","author":"Jennings","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.12.034_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00038-014-0552-z","article-title":"Calculating disability-adjusted life years to quantify burden of disease","volume":"59","author":"Devleesschauwer","year":"2014","journal-title":"Int J Public Health"},{"key":"10.1016\/j.jaip.2024.12.034_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00038-014-0553-y","article-title":"DALY calculation in practice: a stepwise approach","volume":"59","author":"Devleesschauwer","year":"2014","journal-title":"Int J Public Health"},{"key":"10.1016\/j.jaip.2024.12.034_bib13","first-page":"10","article-title":"DALY estimation approaches: understanding and using the incidence-based approach and the prevalence-based approach","volume":"55","author":"Kim","year":"2022","journal-title":"J\u00a0Prev Med Public Health"},{"key":"10.1016\/j.jaip.2024.12.034_bib14","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.12.034_bib15","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/all.12842","article-title":"Development and validation of the mastocytosis quality of life questionnaire: MC-QoL","volume":"71","author":"Siebenhaar","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.12.034_bib17","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","article-title":"Disability weights for the Global Burden of Disease 2013 study","volume":"3","author":"Salomon","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jaip.2024.12.034_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1515\/ijb-2022-0107","article-title":"Agent based modeling in health care economics: examples in the field of thyroid cancer","volume":"19","author":"Demeulemeester","year":"2023","journal-title":"Int J Biostat"},{"key":"10.1016\/j.jaip.2024.12.034_bib19","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.jaip.2022.05.037","article-title":"Refined treatment response criteria for indolent systemic mastocytosis proposed by the ECNM-AIM Consortium","volume":"10","author":"Pyatilova","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"suppl 1","key":"10.1016\/j.jaip.2024.12.034_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5045\/br.2023.2023024","article-title":"Recent advances in diagnosis and therapy in systemic mastocytosis","volume":"58","author":"Lee","year":"2023","journal-title":"Blood Res"},{"key":"10.1016\/j.jaip.2024.12.034_bib21","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2022.040","article-title":"Treatment of indolent and advanced systemic mastocytosis","volume":"14","author":"Buonomo","year":"2022","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.jaip.2024.12.034_bib22","first-page":"525","article-title":"Pre-inpatient evaluation on quality and impact of care in systemic mastocytosis and the influence of hospital stay periods from the perspective of patients: a pilot study","volume":"9","author":"Nowak","year":"2011","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaip.2024.12.034_bib23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(14)60585-7","article-title":"Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis","volume":"383","author":"G\u00fclen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.12.034_bib24","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/jocn.14676","article-title":"Everyday life and mastocytosis from a patient perspective-a qualitative study","volume":"28","author":"Jensen","year":"2019","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1016\/j.jaip.2024.12.034_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2022.102172","article-title":"Living with systemic mastocytosis: Balancing between vulnerability and resilience: a qualitative study","volume":"60","author":"Levedahl","year":"2022","journal-title":"Eur J Oncol Nurs"}],"updated-by":[{"DOI":"10.1016\/j.jaip.2025.07.016","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824012832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824012832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:58:32Z","timestamp":1774256312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824012832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2213219824012832"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.12.034","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifetime Disability-Adjusted Life-Year Assessment of Indolent Systemic Mastocytosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}